1. Home
  2. AHG vs GNFT Comparison

AHG vs GNFT Comparison

Compare AHG & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AHG
  • GNFT
  • Stock Information
  • Founded
  • AHG 2013
  • GNFT 1999
  • Country
  • AHG China
  • GNFT France
  • Employees
  • AHG N/A
  • GNFT N/A
  • Industry
  • AHG Business Services
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AHG Consumer Discretionary
  • GNFT Health Care
  • Exchange
  • AHG Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • AHG 765.9M
  • GNFT 186.3M
  • IPO Year
  • AHG N/A
  • GNFT 2019
  • Fundamental
  • Price
  • AHG $1.66
  • GNFT $3.79
  • Analyst Decision
  • AHG
  • GNFT Strong Buy
  • Analyst Count
  • AHG 0
  • GNFT 1
  • Target Price
  • AHG N/A
  • GNFT $13.00
  • AVG Volume (30 Days)
  • AHG 64.8K
  • GNFT 3.6K
  • Earning Date
  • AHG 07-29-2025
  • GNFT 04-24-2025
  • Dividend Yield
  • AHG N/A
  • GNFT N/A
  • EPS Growth
  • AHG N/A
  • GNFT N/A
  • EPS
  • AHG N/A
  • GNFT 0.03
  • Revenue
  • AHG $8,454,946.00
  • GNFT $73,187,701.00
  • Revenue This Year
  • AHG N/A
  • GNFT $15.98
  • Revenue Next Year
  • AHG N/A
  • GNFT N/A
  • P/E Ratio
  • AHG N/A
  • GNFT $121.41
  • Revenue Growth
  • AHG 281.19
  • GNFT 105.01
  • 52 Week Low
  • AHG $0.74
  • GNFT $2.55
  • 52 Week High
  • AHG $2.35
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • AHG 62.04
  • GNFT 52.34
  • Support Level
  • AHG $1.07
  • GNFT $3.44
  • Resistance Level
  • AHG $1.87
  • GNFT $3.81
  • Average True Range (ATR)
  • AHG 0.19
  • GNFT 0.18
  • MACD
  • AHG 0.06
  • GNFT 0.02
  • Stochastic Oscillator
  • AHG 60.20
  • GNFT 94.55

About AHG Akso Health Group ADS

Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: